Journal of Inflammation Research
Volume 15, 2022 - Issue
Open access
294
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
GIMAP7 as a Potential Predictive Marker for Pan-Cancer Prognosis and Immunotherapy Efficacy
Yan Qin1 Department of Health Management, The People’s Hospital of Guangxi Zhuang Autonomous Region & Research Center of Health Management, Guangxi Academy of Medical Sciences, Nanning, Guangxi, 530021, People’s Republic of Chinahttps://orcid.org/0000-0003-1278-2022View further author information
, He Liu1 Department of Health Management, The People’s Hospital of Guangxi Zhuang Autonomous Region & Research Center of Health Management, Guangxi Academy of Medical Sciences, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Xiaoliang Huang2 Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Lihaoyun Huang2 Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Lixian Liao2 Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Jiasheng Li2 Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Lihua Zhang2 Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
, Wei Li1 Department of Health Management, The People’s Hospital of Guangxi Zhuang Autonomous Region & Research Center of Health Management, Guangxi Academy of Medical Sciences, Nanning, Guangxi, 530021, People’s Republic of ChinaView further author information
& Jianrong Yang1 Department of Health Management, The People’s Hospital of Guangxi Zhuang Autonomous Region & Research Center of Health Management, Guangxi Academy of Medical Sciences, Nanning, Guangxi, 530021, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
show allView further author information
Pages 1047-1061
|
Published online: 15 Feb 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.